BioCentury
ARTICLE | Clinical News

Apo Triavir regulatory update

May 12, 2008 7:00 AM UTC

Apotex Inc., Toronto, Product: Apo Triavir Business: Infectious Rwanda approved Apotex's HIV drug Apo-TriAvir under the Canadian Access to Medicines Regime (CAMR), which allows developing countries t...